METHOD AND KIT FOR PREDICTING OR MONITORING THE RESPONSE OF A CANCER PATIENT TO CHEMOTHERAPY, BASED ON MEASURING THE EXPRESSION LEVEL OF TMEM45A GENE.

Carine Michiels, (Inventor), Lionel Flamant, (Inventor)

Research output: Patent

Abstract

A method for prognosticating the outcome of a cancer, for predicting the response to a chemotherapy treatment of a cancer or for monitoring the response to a chemotherapy treatment of a cancer, comprising the step of measuring the expression level of TMEM45A gene in a sample

Translated title of the contributionMÉTHODE ET TROUSSE PERMETTANT DE PRÉDIRE OU DE SURVEILLER LA RÉACTION D'UN PATIENT CANCÉREUX À LA CHIMIOTHÉRAPIE, À PARTIR DE LA MESURE DU NIVEAU D'EXPRESSION DU GÈNE TMEM45A
Original languageEnglish
Patent numberWO2014009055
IPCC12Q 1/ 68 A I
Priority date22/02/13
Publication statusPublished - 16 Jan 2014

Fingerprint Dive into the research topics of 'METHOD AND KIT FOR PREDICTING OR MONITORING THE RESPONSE OF A CANCER PATIENT TO CHEMOTHERAPY, BASED ON MEASURING THE EXPRESSION LEVEL OF TMEM45A GENE.'. Together they form a unique fingerprint.

Cite this